Leading Japanese manufacturer of functional materials seeks startups for development of new applications for piezoelectric film.
BHP’s vision is for a water-secure world by 2030. Water is an essential resource for BHP’s production and operations.
MIT Startup Exchange presents its September Startup Workshop, centered around real-world IoT and edge computing. Many companies are grappling with how to use IoT and data/AI in their organization to monitor, predict, improve, and transform what they do. Meanwhile, many MIT startups are developing and providing innovative technology solutions to answer these very questions for industry. This workshop will present perspectives from industry leaders, academics, and corporate investors, while also showcasing select MIT startups in the field.
Adam Paxson, CEO; Annica Blake, COO; David Borrelli, CTO Dropwise Technologies
In the coming months, the MIT Industrial Liaison Program (ILP) is pleased to present a special webinar series for China and Southeast Asia featuring leading researchers, field experts, and startups to share insights in energy, nanomaterials, novel photonics, robotics, city planning, healthcare, and more.
AI Driven Bloodless Blood Tests Sean (Shunsuke) Matsuoka, Co-Founder & COO, GPx GPx: https://gpx.ai/
In an aging society, the number of heart failure patients is increasing, making the prevention of readmissions and reduction of medical costs critical issues. Remote monitoring using invasive implantable devices has proven effective in reducing heart failure readmissions, but its use remains limited.
To address this, GPx has developed an algorithm that non-invasively predicts signs of heart failure exacerbation. This algorithm was created using clinical trial data from monitoring 245 heart failure patients over 6 months to a year at eight facilities, including the Mayo Clinic in the U.S. The algorithm links digital biomarker data with vital blood tests (NT-proBNP and creatinine) to achieve high-precision prediction and early medical intervention.
Additionally, with a grant of 1.2 billion yen provided through AMED, we are collaborating with the National Cerebral and Cardiovascular Center (Dr. Chisato Izumi) to conduct a clinical trial involving 400 patients starting April 2025. The trial will be conducted at the National Cerebral and Cardiovascular Center, Kyoto University, Kobe University, and Kochi University.
Furthermore, at this year's MIT Japan Conference, we will unveil a groundbreaking point-of-care (POC) potassium testing device for the first time. At the conference, we aim to explore the feasibility of applying our technology to other conditions (such as kidney failure, pulmonary arterial hypertension, and cardio-oncology) and to assess the potential for providing algorithm-based services for heart failure patients within Japan.
P&G is looking for partners and solutions that support the deactivation, reduction, or elimination of airborne enzyme particles within production environments across operations.
P&G is seeking startups for enabling AI tech: Transforming Consumer Insights Research with IoT, audio, and privacy-preserving video and Synthetic Image and Label Data.